placebo
The efficacy and       safety of inhaled nedocromil sodium (Tilade Mint aerosol) administered using a       Fisonair spacer at a dose of 4 mg three times daily was compared with placebo in        the treatment of asthmatic children aged 6-12 years who are symptomatic and       recovering from an acute exacerbation of asthma.
The efficacy and       safety of inhaled nedocromil sodium (Tilade Mint aerosol) administered using a       Fisonair spacer at a dose of 4 mg three times daily was compared with  @SUBJECT$  in        the  @PREDICAT$  of asthmatic  @OBJECT$  aged 6-12 years who are symptomatic and       recovering from an acute exacerbation of asthma.